Analysts think ANGO stock price could increase by 73%
Jul 30, 2024, 6:26 AM
-3.13%
What does ANGO do
AngioDynamics, Inc., headquartered in Latham, New York, specializes in developing, manufacturing, and selling medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company, which employs 815 people and went public in 2004, offers products across oncology, venous therapies, and vascular interventions.
5 analysts think ANGO stock price will increase by 73.11%. The current median analyst target is $13.26 compared to a current stock price of $7.66. The lowest analysts target is $13.13 and the highest analyst target is $14.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
